Sources | Names Used |
---|---|
CTRPv2 | YL54 |
PharmacoGx | YL54 |
Database | Identifier |
---|---|
Smiles: | CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCNC(C)=O)C(=O)N[C@]1(C)CCCC=C/CCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD2 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | SERTAD1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
mRNA | C11orf40 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | MAGEC2 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
mRNA | IL17RA | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
mRNA | PSMD4 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
mRNA | AREL1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
mRNA | PPFIBP2 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | AMBRA1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
mRNA | ANKRD44 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |